# ELTROMBOPAG OLAMINE
> **ANDA206788** · Abbreviated New Drug Application (Generic) · Sponsor: HETERO LABS LTD V · Approved 2025-01-17
## Drug
- **FDA Application Number:** ANDA206788
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** ELTROMBOPAG OLAMINE
- **Generic name:** ELTROMBOPAG
- **Active ingredients:** ELTROMBOPAG OLAMINE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** HETERO LABS LTD V
- **Manufacturer:** XLCare Pharmaceuticals Inc.
- **First approval:** 2025-01-17
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206788)
---
*AI Analytics · CC0 1.0*